These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6175913)

  • 1. Effect of levamisole treatment on immunological parameters and the early course of cervical cancer.
    Pulay TA; Csömör S
    Neoplasma; 1982; 29(1):81-6. PubMed ID: 6175913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvanticity of vitamin A in advanced irradiated cervical cancer (author's transl)].
    Kucera H
    Wien Klin Wochenschr Suppl; 1980; 118():1-20. PubMed ID: 6162280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy with decaris in the early stages of breast cancer].
    Polevaia EB; Derevnina NA; Trubchaninova LP; Veskova TK
    Vopr Onkol; 1988; 34(10):1182-8. PubMed ID: 3055672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor differentiation and immunocompetence in cervical cancer patients.
    Pulay TA; Csömör A
    Neoplasma; 1979; 26(5):617-21. PubMed ID: 522928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levamisole: a double blind immunological study.
    Webster DJ; Whitehead RH; Richardson G; Hughes LE
    Anticancer Res; 1982; 2(1-2):29-32. PubMed ID: 7051958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of lysozyme chloride on immune responses of patients with uterine cervical cancer].
    Yamaoka K; Yoshioka T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1803-9. PubMed ID: 6882004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM-antigamma globulin antibodies in cervical cancer patients].
    Noeva K
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():78-84. PubMed ID: 305194
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant immunotherapy of carcinoma colli with levamisole. Prevention of immunological depression following surgical therapy and radiotherapy.
    Shiraki S; Mori H; Kadomoto N; Nakano T; Yamada Y; Noda K
    Int J Immunopharmacol; 1982; 4(1):73-80. PubMed ID: 7085141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin tests as immunologic parameters in cervical cancer].
    Wagner G
    Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis.
    Makled M; Rifaat M; Azab M; Makhlouf S; El-Missery A; Khalil N
    Chemioterapia; 1987 Jun; 6(2 Suppl):214-6. PubMed ID: 3509936
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum complement levels in patients with cancer of the uterine cervix before and after radiation therapy.
    Pulay AT; Füst G; Csömör A
    Neoplasma; 1980; 27(2):211-6. PubMed ID: 7393359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole in chronic pyoderma.
    Papageorgiou P; Kesarwala HH; Alcid DV; Szep R; Kulkarni KN; Gocke DJ
    J Clin Lab Immunol; 1982 Jun; 8(2):121-7. PubMed ID: 7108939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of serum concentrations of carcinoembryonic antigens in patients with cervical cancer. 1].
    Schrempel A
    Zentralbl Gynakol; 1984; 106(18):1248-53. PubMed ID: 6506908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.